SURI
SURI
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial...
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 PAGP | Plains GP Holdings, L.P. | 41.11% | 1.27M | $30.98M |
 ACHV | Achieve Life Sciences, Inc. | 9.96% | 1.43M | $7.50M |
 MIST | Milestone Pharmaceuticals Inc. | 6.31% | 3.35M | $4.76M |
 ABEO | Abeona Therapeutics Inc. | 3.84% | 500.34K | $2.89M |
 DCTH | Delcath Systems, Inc. | 3.73% | 261.13K | $2.81M |
 CORT | Corcept Therapeutics Incorporated | 3.48% | 37.76K | $2.62M |
 PHAT | Phathom Pharmaceuticals, Inc. | 3.17% | 249.27K | $2.39M |
 CLDX | Celldex Therapeutics, Inc. | 2.46% | 59.04K | $1.86M |
 OCS | Oculis Holding AG | 2.03% | 66.67K | $1.53M |
 CMPS | COMPASS Pathways plc | 1.98% | 114.28K | $1.49M |
 LONA | LeonaBio, Inc. | 1.89% | 149.28K | $1.42M |
 PALI | Palisade Bio, Inc. | 1.81% | 643.63K | $1.36M |
 IVA | Inventiva S.A. | 1.49% | 227.92K | $1.12M |
 AQST | Aquestive Therapeutics, Inc. | 1.49% | 278.72K | $1.12M |
 ZVRA | Zevra Therapeutics, Inc. | 1.48% | 96.25K | $1.12M |
 KYTX | Kyverna Therapeutics, Inc. | 1.48% | 130.53K | $1.11M |
 OBIO | Orchestra BioMed Holdings, Inc. | 1.14% | 219.39K | $857.80K |
 ARTV | Artiva Biotherapeutics, Inc. | 1.07% | 101.36K | $803.75K |
 OCUL | Ocular Therapeutix, Inc. | 0.97% | 81.05K | $730.27K |
 SABS | SAB Biotherapeutics, Inc. | 0.89% | 187.23K | $674.03K |
SECTOR HOLDINGS
Healthcare
EnergyASSET ALLOCATION BY REGION
United States
Canada
Switzerland
United Kingdom
FranceSECTOR HOLDINGS
Healthcare EnergyASSET ALLOCATION BY REGION
United States Canada Switzerland United Kingdom FranceHoldings (Top 20)
PAGP
Plains GP Holdings, L.P.
ACHV
Achieve Life Sciences, Inc.
MIST
Milestone Pharmaceuticals Inc.
ABEO
Abeona Therapeutics Inc.
DCTH
Delcath Systems, Inc.
CORT
Corcept Therapeutics Incorporated
PHAT
Phathom Pharmaceuticals, Inc.
CLDX
Celldex Therapeutics, Inc.
OCS
Oculis Holding AG
CMPS
COMPASS Pathways plc
LONA
LeonaBio, Inc.
PALI
Palisade Bio, Inc.
IVA
Inventiva S.A.
AQST
Aquestive Therapeutics, Inc.
ZVRA
Zevra Therapeutics, Inc.
KYTX
Kyverna Therapeutics, Inc.
OBIO
Orchestra BioMed Holdings, Inc.
ARTV
Artiva Biotherapeutics, Inc.
OCUL
Ocular Therapeutix, Inc.
SABS
SAB Biotherapeutics, Inc.